BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers

(2010) Henne Holstege et al.   BMC CANCER

Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients

(2010) H. M. Horlings et al.   CLINICAL CANCER RESEARCH

BRD7 is a candidate tumour suppressor gene required for p53 function

(2010) Jarno Drost et al.   NATURE CELL BIOLOGY

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

(2009) SR Young et al.   BMC CANCER

High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer

(2009) H. Holstege et al.   CANCER RESEARCH

High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

(2009) E. Manie et al.   CANCER RESEARCH

Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept

(2009) Sabine C. Linn et al.   EUROPEAN JOURNAL OF CANCER

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence

(2009) H Helmbold et al.   ONCOGENE

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

(2008) Simon A. Joosse et al.   BREAST CANCER RESEARCH AND TREATMENT

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

(2008) T. Byrski et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk

(2008) Jiali Han et al.   BREAST CANCER RESEARCH AND TREATMENT

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

(2008) B. P. Schneider et al.   CLINICAL CANCER RESEARCH

A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair

(2008) Alan Ashworth   JOURNAL OF CLINICAL ONCOLOGY

Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data

(2008) Christiaan Klijn et al.   NUCLEIC ACIDS RESEARCH